Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements

Cell Biochemistry and Function

Volumn 32, Issue 7, 2014, Pages 547-556

  Wu, Guodong ^a   Ji, Zhiyong ^a   Li, Haifeng ^a   Lei, Yu ^a   Jin, Xiaoyuan ^a   Yu, Yingqing ^a   Sun, Mingli ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Adenovirus; Lung cancer; miR 133a; miR 137; miR 449a; TRAIL

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; CASPASE 3; MESSENGER RNA; MICRORNA; MICRORNA 133A; MICRORNA 137; MICRORNA 449A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; MIRN137 MICRORNA, HUMAN; MIRN449 MICRORNA, HUMAN;

A549 CELL LINE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; LIVER TOXICITY; LUNG CANCER; MALE; MICRORNA RESPONSE ELEMENT; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA STRUCTURE; TUMOR XENOGRAFT; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DNA RESPONSIVE ELEMENT; GENE VECTOR; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PRIMARY CELL CULTURE; TUMOR CELL LINE; XENOGRAFT;

ADENOVIRIDAE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC VECTORS; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PRIMARY CELL CULTURE; RESPONSE ELEMENTS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84914148175     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3042     Document Type: Article

References (35)

1. Humphrey L, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US preventive services task force recommendation. Ann Intern Med 2013; 17: 411-420.
2. Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997; 276: 111-113.
3. Huang Y, Sheikh MS. TRAIL death receptors and cancer therapeutics. Toxicol Appl Pharmacol 2007; 224: 284-289.
4. Camidge DR. The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer. Clin Lung Cancer 2007; 8: 413-419.
5. Sun SY, Yue P, Hong WK, Lotan R. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Cancer Res 2000; 60: 7149-7155.
6. Chen W, Wang X, Zhuang J, Zhang L, Lin Y. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis 2007; 28: 2114-2121.
7. Seol JY, Park KH, Hwang CI, et al. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Ther 2003; 10: 540-548.
8. Jang SH, Seol JY, Kim CH, et al. Additive effect of TRAIL and p53 gene transfer on apoptosis of human lung cancer cell lines. Int J Mol Med 2004; 13: 181-186.
9. Yang F, Shi P, Xi X, et al. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC). Med Oncol 2006; 23: 191-204.
10. Reddy RM, Tsai WS, Ziauddin MF, et al. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand. J Thorac Cardiovasc Surg 2004; 128: 883-891.
11. Voortman J, Resende TP, Abou El Hassan MA, Giaccone G, Kruyt FA. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib. Mol Cancer Ther 2007; 6: 2103-2112.
12. Aydin C, Sanlioglu AD, Bisgin A, et al. NF-kappaB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC Cancer 2010; 10: 584.
13. Soria JC, Smit E, Khayat D, et al. Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer. J Clin Oncol 2010; 28: 1527-1533. doi:10.1200/JCO.2009.25.4847.
14. Soria JC, Mark Z, Zatloukal P, et al. Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol 2011; 29: 4442-4451. doi:10.1200/JCO.2011.37.2623.
15. Corazza N, Jakob S, Schaer C, et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 2006; 116: 2493-2499.
16. Armeanu S, Lauer UM, Smirnow I, et al. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res 2003; 63: 2369-2372.
17. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell 2005; 122: 9-12.
18. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
19. Mallick R, Patnaik SK, Yendamuri S. MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog 2010; 9: 8.
20. Moriya Y, Nohata N, Kinoshita T, et al. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet 2012; 57: 38-45.
21. Zhu X, Li Y, Shen H, et al. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett 2013; 587: 73-81.
22. Luo W, Huang B, Li Z, et al. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS One 2013; 8: e64759.
23. Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 854-858.
24. Dimberg LY, Anderson CK, Camidge R, Behbakht K, Thorburn A, Ford HL. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 2013; 32: 1341-1350.
25. Zhao Y, Li Y, Wang Q, Wang L, Yang H, Li M. Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers. Mol Cell Biochem 2011; 353: 93-99.
26. Cherneva R, Georgiev O, Dimova I, Rukova B, Petrov D, Toncheva D. EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups. Biomark Cancer 2010; 2: 57-63.
27. Song JS, Kim HP. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line. Oncol Rep 2004; 12: 443-447.
28. Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol 2002; 128: 554-560.
29. Zhang Y, Ma H, Liu SL, Liu YX, Zheng DX. Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy. Zhonghua Yi Xue Za Zhi 2008; 88: 475-479.
30. Cortinovis D, Monica V, Pietrantonio F, Ceresoli G, La S, Wannesson L. MicroRNAs in Non-Small Cell Lung Cancer: Current Status and Future Therapeutic Promises. Curr Pharm Des 2013; 20: 3982-3990.
31. Bo Y, Guo G, Yao W. MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth. J Neurooncol 2013; 112: 27-37.
32. Liu J, Ma L, Li C, Zhang Z, Yang G, Zhang W. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol 2013; 7: 1043-1155.
33. Ma L, Liu J, Shen J, et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 2010; 9: 554-561.
34. Wang B, Wang H, Yang Z. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS One 2012; 7: e47053.
35. Wang B, Liu J, Ma LN, et al. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling. J Gastroenterol 2013; 48: 798-808.